ALLR Allarity Therapeutics Inc

Price (delayed)

$1.43

Market cap

$441,791

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$205.2

Enterprise value

$1.58M

Highlights

Allarity Therapeutics's EPS has surged by 100% YoY and by 98% QoQ

Allarity Therapeutics's net income has increased by 26% YoY and by 9% QoQ

The company's debt has shrunk by 65% YoY but it rose by 11% QoQ

Allarity Therapeutics's quick ratio has shrunk by 94% YoY and by 89% QoQ

Sector: Healthcare

Industry: Biotechnology

Peers: OMER OMGA

Key stats

What are the main financial stats of ALLR

Market

Shares outstanding

308,945

Market cap

$441,791

Enterprise value

$1.58M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

N/A

Price to sales (P/S)

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Earnings

Revenue

EBIT

-$11.32M

EBITDA

-$11.28M

Free cash flow

-$12.75M

Per share

EPS

-$205.2

Free cash flow per share

-$128.04

Book value per share

-$12.07

Revenue per share

TBVPS

$20

Balance sheet

Total assets

$11.86M

Total liabilities

$14.61M

Debt

$1.3M

Equity

-$2.75M

Working capital

-$12.2M

Liquidity

Debt to equity

-0.47

Current ratio

0.14

Quick ratio

0.01

Net debt/EBITDA

-0.1

Margins

EBITDA margin

N/A

Gross margin

N/A

Net margin

N/A

Operating margin

N/A

Efficiency

Return on assets

-157.5%

Return on equity

N/A

Return on invested capital

N/A

Return on capital employed

N/A

Return on sales

N/A

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

ALLR stock price

How has the Allarity Therapeutics stock price performed over time

Intraday

4.38%

1 week

-7.14%

1 month

-76.79%

1 year

-99.63%

YTD

-87.03%

QTD

-76.25%

Financial performance

How have Allarity Therapeutics's revenue and profit performed over time

Revenue

Gross profit

Operating income

-$17.13M

Net income

-$11.9M

Gross margin

N/A

Net margin

N/A

ALLR's operating income has surged by 50% year-on-year and by 10% since the previous quarter

Allarity Therapeutics's net income has increased by 26% YoY and by 9% QoQ

Growth

What is Allarity Therapeutics's growth rate over time

Valuation

What is Allarity Therapeutics stock price valuation

P/E

N/A

P/B

N/A

P/S

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Allarity Therapeutics's EPS has surged by 100% YoY and by 98% QoQ

ALLR's equity is up by 19% from the previous quarter

Efficiency

How efficient is Allarity Therapeutics business performance

Allarity Therapeutics's ROA has plunged by 63% YoY

Dividends

What is ALLR's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for ALLR.

Financial health

How did Allarity Therapeutics financials performed over time

ALLR's total assets is 19% less than its total liabilities

Allarity Therapeutics's quick ratio has shrunk by 94% YoY and by 89% QoQ

The current ratio has dropped by 68% year-on-year and by 50% since the previous quarter

The company's debt is 147% higher than its equity

ALLR's debt to equity has surged by 99% year-on-year but it is down by 34% since the previous quarter

The company's debt has shrunk by 65% YoY but it rose by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.